Table 2.

The diagnostic performance assessed by the parameters.

Indicators	AUC (95% CI)	Sensitivity (95% CI)	Specificity (95% CI)	PLR (95% CI)	NLR (95% CI)	DOR (95% CI)
Poorly differentiated HCC
MK	0.89 (0.86, 0.91)	0.69 (0.56, 0.80)#	0.94 (0.84, 0.98)&	10.7 (4.4, 26.0)	0.33 (0.23, 0.48)	32 (13, 80)
D	0.89 (0.86, 0.92)	0.87 (0.75, 0.93)#	0.80 (0.72, 0.86)#	4.4 (2.9, 6.5)	0.17 (0.08, 0.33)	26 (10, 68)
ADCmean	0.86 (0.83, 0.89)	0.82 (0.75, 0.88)#	0.75 (0.68, 0.82)#	3.4 (2.5, 4.5)	0.23 (0.17, 0.33)	14 (8, 24)
ADCmin	0.81 (0.78, 0.84)	0.83 (0.67, 0.92)&	0.64 (0.51, 0.75)#	2.3 (1.7, 3.1)	0.27 (0.13, 0.52)	9 (4, 20)
Well-differentiated HCC
ADCmean	0.90 (0.87, 0.92)	0.82 (0.73, 0.89)#	0.88 (0.75, 0.95)#	7.0 (3.0, 16.2)	0.20 (0.12, 0.34)	34 (10, 120)
D	0.92 (0.89, 0.94)	0.87 (0.76, 0.93)&	0.83 (0.78, 0.87)&	5.1 (3.8, 6.9)	0.16 (0.08, 0.30)	32 (14, 73)
MVI(+) vs. MVI(-)
ADCmean	0.78 (0.74, 0.81)	0.74 (0.68, 0.79)&	0.71 (0.61, 0.80)#	2.6 (1.9, 3.5)	0.37 (0.30, 0.45)	7 (5, 11)
D	0.87 (0.83, 0.89)	0.80 (0.72, 0.86)&	0.80 (0.73, 0.85)&	3.9 (2.9, 5.3)	0.25 (0.18, 0.36)	15 (9, 27)

&, the fixed effect model; #, the random effect model; ADCmean, mean apparent diffusion coefficient; ADCmin, minimum apparent diffusion coefficient; MK, mean kurtosis; MVI, microvascular invasion; AUC, area under the curve; PLR, positive likelihood ratio; NLR, negative likelihood ratio; DOR, diagnostic odds ratio; HCC, hepatocellular carcinoma.